• Taking hypertension medication "anyTIME"

    The TIME trial reported that taking antihypertensives mornings or evenings, provides identical protection against heart attack, stroke, or vascular death.

  • First RCT evidence for use of AI in daily practice

    After blinded review of initial LVEF assessment, cardiologists were less likely to substantially change final reports with initial AI than sonographer assessment.

  • Polypill SECUREs win in secondary prevention in elderly

    The 'polypill' dose of aspirin, ramipril, and atorvastatin prevents secondary CV events in people ≥65 years old who previously had myocardial infarction.

  • Minimally invasive tumour treatment done via histotripsy

    Focused ultrasound waves can be used to destroy tissue with millimetre precision. The innovative technology is being tested in the 'HOPE4LIVER' study.

  • Trial results: dapagliflozin DELIVERs for HFmrEF/HFpEF

    Dapagliflozin reduced cardiovascular death risk or worsening heart failure in patients with mildly reduced and preserved ejection fraction.

  • Fears of neprilysin inhibition effects on cognition removed

    Trial results show no evidence that neprilysin inhibition raised cognitive impairment risk due to brain amyloid-β accumulation, for HFmrEF/HFpEF patients.

  • mRNA vaccines and broadly neutralising antibodies

    mRNA vaccines should induce viral proteins directly in the body and stimulate the immune system to produce broadly neutralising antibodies against HIV.

  • HIV vaccination: A step closer thanks to COVID-19 vaccines?

    Vaccine prospects were revolutionised thanks to new mRNA vaccines against COVID-19. Can this knowledge transfer for the HIV vaccine quest?

  • HIV: Is a cure possible with immunotherapies?

    ARTs for HIV treatment are highly effective, but rebounds occurs after medicine discontinuation. This article looks at developing treatment options in this field.

  • The good news: Uganda tackles the challenges of AIDS

    In Uganda, AIDS-related mortality has dropped rapidly. Quick HIV tests and more screening options are just some of the measures helping the developing country.

  • HIV reservoirs: New results on viral tracing

    Modern HIV therapies cannot yet remove the viruses from the body. Treatments that attack viral reservoirs are of great hope to eliminate HIV in a patient.

  • New HIV drugs are on the way

    Current HIV therapy pushes the virus below detection limits. The virus can then no longer be passed on. However, HIV is very variable, so the therapeutic sword must be constantly sharpened.

  • How to close the HIV information gap?

    Worldwide, only about 84% of people living with HIV know their viral status. New recommendations aim to reach the remaining 16%.

  • HIV and suicide in adolescence and young adulthood

    The suicide rate worldwide has increased by 60% in the last 45 years. A significant increase can be seen in the group of adolescents and young adults with HIV.

  • New WHO guideline on HIV, viral hepatitis and STDs

    The WHO guidelines for the prevention, diagnosis and treatment of AIDS in at-risk populations has been expanded to include viral hepatitis and STDs.

  • South Africa: Suicidality among HIV+ young women

    The Southern African region has the world's highest HIV infection rate in women 15-24 years old. Suicidal behaviour is common and two studies look into this.

  • Ageing with HIV: faster, lonelier, poorer?

    Growing old is associated with social, financial and health problems. But if a lifelong HIV infection is added to this, ageing can often become a challenge.

  • HIV and co-infections: Pathways to elimination

    HIV rarely comes alone. That is why research takes a closer look at HIV viruses, and also at important pathogens of other infections like hepatitis and tuberculosis.

  • Breastfeeding with HIV positivity - is it possible?

    The WHO advises HIV-positive mothers against breastfeeding to avoid transmission. But more countries are now providing their own recommendations.

  • HIV and hepatitis B: News on their clinical management

    When people with HIV also have hepatitis B, clinical management can be complicated. Next is an update on optimising diagnostics and therapy.

  • 3 |
  • 4 |
  • 5 |
  • 6 |
  • 7 |
  • 8 |
  • 9 |
  • 10 |
  • 11 |
  • 12 |
  • 13 |